Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Sales (2018 - 2025)

Bicycle Therapeutics' Return on Sales history spans 8 years, with the latest figure at 4.26% for Q4 2025.

  • For Q4 2025, Return on Sales fell 3020.0% year-over-year to 4.26%; the TTM value through Dec 2025 reached 0.08%, down 33.0%, while the annual FY2025 figure was 0.08%, 22.0% down from the prior year.
  • Return on Sales reached 4.26% in Q4 2025 per BCYC's latest filing, up from 5.04% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 34.46% in Q4 2024 to a low of 27.04% in Q2 2025.
  • Average Return on Sales over 5 years is 5.62%, with a median of 6.61% recorded in 2022.
  • Peak YoY movement for Return on Sales: surged 4306bps in 2024, then plummeted -3020bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 11.26% in 2021, then skyrocketed by 63bps to 4.16% in 2022, then crashed by -107bps to 8.6% in 2023, then soared by 501bps to 34.46% in 2024, then tumbled by -88bps to 4.26% in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Return on Sales are 4.26% (Q4 2025), 5.04% (Q3 2025), and 27.04% (Q2 2025).